109 related articles for article (PubMed ID: 344227)
1. The diagnostic application of specific antiprocollagen sera. II. Analysis of liver biopsies.
Wick G; Brunner H; Penner E; Timpl R
Int Arch Allergy Appl Immunol; 1978; 56(4):316-24. PubMed ID: 344227
[TBL] [Abstract][Full Text] [Related]
2. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
3. Immunofluorescence with specific antisera to collagen and procollagen as a new diagnostic tool.
Wick G
Suppl Thromb Haemost; 1978; 63():181-5. PubMed ID: 400455
[No Abstract] [Full Text] [Related]
4. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of type III collagen and procollagen in cirrhotic human liver using monoclonal antibodies.
Sakakibara K; Ooshima A; Igarashi S; Sakakibara J
Virchows Arch A Pathol Anat Histopathol; 1986; 409(1):37-46. PubMed ID: 3085339
[TBL] [Abstract][Full Text] [Related]
6. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of antithrombin III and aminopyrine breath test in liver disease.
Rodzynek JJ; Preux C; Leautaud P; Abramovici J; Di Paolo A; Delcourt AA
Arch Intern Med; 1986 Apr; 146(4):677-80. PubMed ID: 3963948
[TBL] [Abstract][Full Text] [Related]
9. Procollagen type I production by hepatocytes: a marker of progressive liver disease?
Malizia G; Giannuoli G; Caltagirone M; Pisa R; Pagliaro L
Lancet; 1987 Nov; 2(8567):1055-7. PubMed ID: 2889966
[TBL] [Abstract][Full Text] [Related]
10. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
[TBL] [Abstract][Full Text] [Related]
11. Procollagen synthesized by newborn rat skin in culture.
Mitrani E; Marks R
Br J Exp Pathol; 1979 Feb; 60(1):76-84. PubMed ID: 380622
[TBL] [Abstract][Full Text] [Related]
12. [Results of liver scintigraphy in chronic liver diseases].
Endert G; Banzhaf E; Sensing H
Z Arztl Fortbild (Jena); 1976 May; 70(9):467-70. PubMed ID: 936673
[No Abstract] [Full Text] [Related]
13. [Diagnosis of hepatitis with special reference to the viral form].
Fábregas Rodríguez C; Hurtado de Mendoza Amat J; Alvarez Blanco J
Rev Cubana Med Trop; 1980; 32(3):211-8. PubMed ID: 6454226
[TBL] [Abstract][Full Text] [Related]
14. Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseases.
Müller A; Krombholz B; Pott G; Machnik G; Vollandt R; Reinhardt M; Jorke D
Clin Chim Acta; 1991 Feb; 197(1):59-66. PubMed ID: 1646085
[TBL] [Abstract][Full Text] [Related]
15. Preparation and use in immunohistology of antibodies specific for type I and type III collagen and procollagen.
Nowack H; Gay S; Wick G; Becker U; Timpl R
J Immunol Methods; 1976; 12(1-2):117-24. PubMed ID: 792345
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic significance of the liver scintigraphy in chronic liver diseases : comparison with liver needle biopsy].
Spreafico G; Colombo L; Rocca F; Puricelli G; Lampertico P
Recenti Prog Med; 1975 Aug; 59(2):138-48. PubMed ID: 1243905
[No Abstract] [Full Text] [Related]
17. [Liver diseases from the viewpoint of blind needle biopsy. Value and limitations of percutaneous liver biopsy].
Sarvan B; Broicher H
Dtsch Med Wochenschr; 1970 Jan; 95(3):105-10. PubMed ID: 5411219
[No Abstract] [Full Text] [Related]
18. Use of the "Ekho-11" apparatus for diagnosing some liver diseases in children.
Dvoryakovskii IV
Biomed Eng (NY); 1975 Mar; 8(3):171-3. PubMed ID: 1109605
[No Abstract] [Full Text] [Related]
19. Localization of type III procollagen mRNA in areas of liver fibrosis by in situ hybridization.
Yamada H; Aida T; Taguchi K; Asano G
Acta Pathol Jpn; 1989 Nov; 39(11):719-24. PubMed ID: 2515744
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of the indocyanine green test in the diagnosis of chronic liver diseases.
Janecki J; Kubicki S
Pol Med J; 1969; 8(1):50-6. PubMed ID: 4889491
[No Abstract] [Full Text] [Related]
[Next] [New Search]
